Table 2.
2009 assessment of adults for mf prevalence (N = 775) and nodule prevalence (N = 1,015) in three health districts (Touboro, Tchollire, and Rey-Bouba) of North Region, Cameroon
| Community name | Assessment (2009) | 1993–2009 treatments | Years under treatment | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mf prevalence | Nodule prevalence | |||||||||
| Number assessed | Mean age | Number of persons + ve | Percent of persons with mf | Number assessed for nodules | Number of persons + ve | Percent of persons with nodules | Percent eligible population treated range | Mean treatment coverage (%) | ||
| Touboro | ||||||||||
| Sora-Mbourn | 67 | 22.0 | 3 | 4.5 | 113 | 19 | 16.8 | 72.7–100.0 | 97.2 | 17 |
| Reh | 59 | 27.5 | 2 | 3.4 | 57 | 8 | 14.0 | 81.0–100.0 | 87.0 | |
| Ribao | 70 | 29.9 | 0 | 0.0 | 175 | 25 | 14.3 | 71.0–100.0 | 85.0 | |
| Koumane | 70 | 29.2 | 6 | 8.6 | 144 | 27 | 18.8 | 81.0–98.0 | 85.6 | |
| Koubao | 70 | 47.5 | 9 | 12.9 | 36 | 19.5 | 22.8 | 84.0–99.0 | 88.7 | |
| Babidan | 70 | 30.2 | 12 | 17.1 | 121 | 28 | 23.1 | 73.3–97.0 | 87.2 | |
| Subtotal | 406 | 31.0 | 32 | 7.7 | 646 | 123 | 23.3 | |||
| Tchollire | ||||||||||
| Yokout | 70 | 34.6 | 0 | 0.0 | 70 | 1 | 1.4 | 76.8–96.6 | 81.4 | 12 |
| Douffin | 60 | 31.3 | 0 | 0.0 | 60 | 0 | 0.0 | 81.0–100.0 | 94.0 | |
| Laboun | 60 | 27.0 | 0 | 0.0 | 60 | 2 | 3.1 | 85.0–100.0 | 96.5 | |
| Mayo-Galké | 60 | 28.6 | 2 | 3.3 | 60 | 5 | 8.3 | 94.0–100.0 | 94.1 | |
| Subtotal | 250 | 30.4 | 2 | 0.8 | 250 | 8 | 3.3 | |||
| Ray-Bouba | ||||||||||
| Larki | 59 | 28.2 | 0 | 0.0 | 59 | 2 | 3.4 | 94.2–100.0 | 94.4 | 12 |
| Rey-Manga | 60 | 37.1 | 3 | 5.0 | 60 | 1 | 1.7 | 95.0–98.1 | 96.3 | |
| Subtotal | 119 | 32.6 | 3 | 2.5 | 119 | 3 | 2.5 | |||
| Grand total | 775 | 38.9 | 37 | 4.8 | 1,015 | 137 | 13.5 | 71.0–100.0 | 90.6 | 12–17 |
Reported mean ivermectin treatment coverage from 1993 to 2009 is also shown.